stage ivb ovarian cancer ajcc v8
Showing 1 - 16 of 16
Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8
Recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +26 more
- Biopsy
- +10 more
-
Duarte, California
- +2 more
Jan 25, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +20 more
- Pembrolizumab
- Ziv-Aflibercept
-
Tampa, Florida
- +8 more
Jan 3, 2023
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker
Recruiting
- BRCA1 Gene Mutation
- +19 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
New Brunswick, New Jersey
- +1 more
Nov 16, 2022
Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous
Recruiting
- Low Grade Fallopian Tube Serous Adenocarcinoma
- +36 more
- Carboplatin
- +2 more
-
Anchorage, Alaska
- +674 more
Nov 2, 2022
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium
Recruiting
- Advanced Malignant Solid Neoplasm
- +22 more
- TRPV6 Calcium Channel Inhibitor SOR-C13
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial
Recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +32 more
- Carboplatin
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Remote Telemonitoring of Patient-Generated Physiologic Health
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +171 more
- Patient Monitoring
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Malignant Female Reproductive System Tumor, Recurrent Cervical Carcinoma, Recurrent Endometrial Carcinoma Trial in Houston
Recruiting
- Malignant Female Reproductive System Neoplasm
- +24 more
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 6, 2022
BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston (Chemotherapy, Olaparib, Therapeutic
Recruiting
- BRCA-Mutated Ovarian Carcinoma
- +30 more
- Chemotherapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 27, 2022
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,
Recruiting
- Advanced Breast Carcinoma
- +73 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
May 5, 2022
Developing a Test for the Detection of Ovarian Cancer
Recruiting
- Ovarian Neoplasms
- +14 more
- Uterine lavage, or a wash of the womb
- +2 more
-
Little Rock, Arkansas
- +5 more
Apr 29, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8 Trial in
Not yet recruiting
- Stage II Fallopian Tube Cancer AJCC v8
- +33 more
- Alpha-type-1 Polarized Dendritic Cells
- Autologous Natural Killer Cell-like CTLs
-
Buffalo, New YorkRoswell Park Cancer Institute
Apr 1, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +51 more
- Dostarlimab
- Niraparib
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 15, 2022
Pharmacogenomics Testing in Directing Optimal Use of Supportive
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +45 more
- Biospecimen Collection
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Feb 3, 2022
Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston
Recruiting
- Advanced Endometrial Carcinoma
- +36 more
- Glutaminase Inhibitor IPN60090
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Sep 9, 2021